In ₹ Crore except Per Share Latest Annual | SHREECEM FY26 | ULTRACEMCO FY26 | AMBUJACEM FY26 | ACC FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 47.30× | 39.45× | 20.70× | ◆ 11.03× | 20.70× +128% | |
| P/B | 3.54× | 4.00× | 1.36× | ◆ 1.15× | 1.36× +159% | |
| EV/EBITDA | 16.30× | 20.06× | 14.86× | ◆ 7.81× | 14.86× +10% | |
| Market Cap | ₹82,461 Cr | ₹3.23L Cr | ₹97,982 Cr | ₹23,593 Cr | ₹97,982 Cr -16% | |
| Growth | ||||||
| Revenue CAGR 3Y | 5.47% | ◆ 11.86% | 7.03% | 9.16% | 9.16% -40% | |
| Revenue CAGR 5Y | 9.22% | ◆ 14.63% | 7.02% | 9.96% | 9.96% -7% | |
| Net Income CAGR 3Y | 11.28% | ◆ 17.30% | 5.96% | -2.93% | 5.96% +89% | |
| Revenue YoY (latest Q) | ◆ 18.03% | 15.85% | -7.67% | -4.59% | -4.59% +493% | |
| Net Income YoY (latest Q) | -17.48% | ◆ 17.24% | -31.93% | -60.84% | -31.93% +45% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 22.14% | 19.23% | 16.08% | 11.36% | 16.08% +38% | |
| Net Income Margin | 8.35% | 9.25% | ◆ 13.87% | 8.23% | 9.25% -10% | |
| Return on Common Equity | 7.48% | 10.12% | 6.58% | ◆ 10.40% | 10.12% -26% | |
| Return on Capital Employed | 7.53% | ◆ 11.51% | 3.88% | 8.42% | 8.42% -11% | |
| Return on Assets | 5.56% | 5.79% | 6.29% | ◆ 7.76% | 6.29% -12% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.07× | 0.28× | ◆ 0.00× | 0.00× | 0.00× | |
| Interest Coverage | 8.71× | 6.61× | 13.28× | ◆ 16.35× | 13.28× -34% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹20,943 Cr | ₹88,512 Cr | ₹40,656 Cr | ₹25,962 Cr | ₹40,656 Cr -48% | |
| Net Income | ₹1,749 Cr | ₹8,188 Cr | ₹5,637 Cr | ₹2,137 Cr | ₹5,637 Cr -69% | |
| Total Assets | ₹31,476 Cr | ₹1.41L Cr | ₹89,607 Cr | ₹27,525 Cr | ₹89,607 Cr -65% | |
| EPS | ₹483.24 | ₹277.62 | ₹19.15 | ₹113.8 | ₹113.8 +325% | |
| Book Value per Share | ₹6,461.78 | ₹2,738.99 | ₹290.66 | ₹1,093.38 | ₹1,093.38 +491% | |